These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4299465)

  • 21. [Vitamin E difficiency in man and the action mechanism of vitamin E].
    Gerlóczy F
    Orv Hetil; 1968 Apr; 109(17):897-907. PubMed ID: 4882138
    [No Abstract]   [Full Text] [Related]  

  • 22. Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study.
    Furukawa S; Yasuda S; Amengual O; Horita T; Atsumi T; Koike T
    Ann Rheum Dis; 2006 Aug; 65(8):1118-20. PubMed ID: 16837498
    [No Abstract]   [Full Text] [Related]  

  • 23. [Resolution of scleroderma renal crisis with thrombotic microangiopathy. Case report (author's transl)].
    Rebaiz K; Birembaut P; Charneau A; Petit J; Wolf C
    Nephrologie; 1980; 1(3):137-41. PubMed ID: 7027064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of unithiol on collagen metabolism in systemic scleroderma].
    Pasieshvili LM
    Vopr Revm; 1980; (1):57-8. PubMed ID: 7385751
    [No Abstract]   [Full Text] [Related]  

  • 26. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
    Sych LI; Trofimova LIa
    Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the therapy of muscular diseases].
    Mittelbach F; Bodechtel G
    Munch Med Wochenschr; 1968 Sep; 110(36):1988-93. PubMed ID: 5695705
    [No Abstract]   [Full Text] [Related]  

  • 28. Raynaud's phenomenon and scleroderma.
    Harper FE; LeRoy EC
    Compr Ther; 1981 Feb; 7(2):45-51. PubMed ID: 6163587
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic trial with fucidin in systemic scleroderma].
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowski J; Mozdzanowska K
    Z Hautkr; 1984 Dec; 59(23):1611-9. PubMed ID: 6395525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ethylenediaminetetraacetic acid (EDTA) and tetrahydroxyquinone on sclerodermatous skin. Histologic and chemical studies.
    Keech MK; McCann DS; Boyle AJ; Pinkus H
    J Invest Dermatol; 1966 Sep; 47(3):235-46. PubMed ID: 4958819
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic effect of alpha-tocopher- yl-quinone on muscular disorders of hyperthyroidism and of prolonged treatment by corticoids and antimitotics].
    Richier JL; Guérin D; Leblay R; Pony JC
    Sem Hop; 1969 Apr; 45(20):1406-12. PubMed ID: 4307006
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of systemic scleroderma based on connective tissue metabolism].
    Tamura T; Hattori A; Ishikawa E
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):770-3. PubMed ID: 304921
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of 100-day treatment of generalized scleroderma with imuran].
    Czernielewski A; Olszewska Z
    Przegl Dermatol; 1973; 60(6):761-7. PubMed ID: 4769960
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of scleroderma with alpha-tocopherol].
    BOZKOWA K
    Pol Tyg Lek (Wars); 1957 Apr; 12(16):606-8. PubMed ID: 13452974
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies in 25 patients with progressive systemic scleroderma treated by long-term administration of griseofulvin].
    Giordano M; Ara M; Capelli L; Tirri G; Pettinato G; Vatti M
    Minerva Med; 1973 Jun; 64(46):2451-66. PubMed ID: 4579328
    [No Abstract]   [Full Text] [Related]  

  • 37. A descriptive and prognostic study of systemic sclerosis-associated myopathies.
    Ranque B; Authier FJ; Le-Guern V; Pagnoux C; Berezne A; Allanore Y; Launay D; Hachulla E; Kahan A; Cabane J; Gherardi R; Guillevin L; Mouthon L
    Ann Rheum Dis; 2009 Sep; 68(9):1474-7. PubMed ID: 19054827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Griseofulvin administered for an indeterminate time in the therapy of systemic scleroderma and Raynaud's syndrome].
    Giordano M; Capelli L; Ara M; Tirri G
    Reumatismo; 1971; 23(2):82-92. PubMed ID: 5146109
    [No Abstract]   [Full Text] [Related]  

  • 39. [Local myopathy in trotting horses].
    Wintzer HJ; von Glasenapp H
    Berl Munch Tierarztl Wochenschr; 1973 Jun; 86(12):221-5. PubMed ID: 4738621
    [No Abstract]   [Full Text] [Related]  

  • 40. [1ST REMARKS ON THE USE OF THE ALPHA-QUINONE OF TOCOPHEROL IN BALANO-PREPUTIAL SCLEROATROPHY].
    FAYOLLE J; MEUNIER P
    Lyon Med; 1964 Jun; 211():1786-7. PubMed ID: 14174671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.